SitahopeTM – M
sitahope-m
SitahopeTM– M
This combination medication is used to improve glycemic control in adults with type 2 diabetes mellitus. It combines sitagliptin, a DPP-4 inhibitor, with metformin, a biguanide, to provide a synergistic approach to lowering blood glucose levels.
Indications:
Type 2 Diabetes Mellitus:
- Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- Suitable for patients who are inadequately controlled on metformin alone or those already being treated with both sitagliptin and metformin.
Available as
TabletsFor use with
AdultsStrength
Sitagliptin 50mg plus metformin 500mg SR
Sitagliptin 100mg plus Metformin 500mg SR